Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Blake

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
Seminars in Nuclear Medicine|July 1, 1997
Interpretation of bone densitometry studiesG M Blake, I Fogelman
Endocrinology and Metabolism Clinics of North America|July 21, 1998
Applications of bone densitometry for osteoporosisG M Blake, I Fogelman
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|September 28, 1999
Doses from dual-Xray absorptiometry (DXA) scanning to reproductive tissues of femalesC F Njeh, G M Blake
European Journal of Nuclear Medicine|January 1, 1983
A new method giving a two criteria diagnosis of venous occlusion using isotope imaging of 99mTc-labelled fibrinogenJ F Martin, G M Blake
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1995
Patient dose in morphometric X-ray absorptiometryM K Lewis, G M Blake
Calcified Tissue International|February 20, 2007
Peripheral and central measurements of bone mineral density are equally strongly associated with clinical risk factors for osteoporosisR Patel, G M Blake, I Fogelman
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|August 12, 2004
Peripheral or axial bone density measurements?G M Blake, R Patel, I Fogelman
Calcified Tissue International|October 31, 2001
Changes in QUS and BMD measurements with antiresorptive therapy: a two-year longitudinal studyM L Frost, G M Blake, Fogelman
Scandinavian Journal of Rheumatology|March 18, 2000
The time of day that etidronate is ingested does not influence its therapeutic effect in osteoporosisG J Cook, G M Blake, I Fogelman
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 9, 2000
Contact quantitative ultrasound: an evaluation of precision, fracture discrimination, age-related bone loss and applicability of the WHO criteriaM L Frost, G M Blake, I Fogelman
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
Seminars in Nuclear Medicine|July 1, 1997
Interpretation of bone densitometry studiesG M Blake, I Fogelman
Endocrinology and Metabolism Clinics of North America|July 21, 1998
Applications of bone densitometry for osteoporosisG M Blake, I Fogelman
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|September 28, 1999
Doses from dual-Xray absorptiometry (DXA) scanning to reproductive tissues of femalesC F Njeh, G M Blake
European Journal of Nuclear Medicine|January 1, 1983
A new method giving a two criteria diagnosis of venous occlusion using isotope imaging of 99mTc-labelled fibrinogenJ F Martin, G M Blake
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1995
Patient dose in morphometric X-ray absorptiometryM K Lewis, G M Blake
Calcified Tissue International|February 20, 2007
Peripheral and central measurements of bone mineral density are equally strongly associated with clinical risk factors for osteoporosisR Patel, G M Blake, I Fogelman
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|August 12, 2004
Peripheral or axial bone density measurements?G M Blake, R Patel, I Fogelman
Calcified Tissue International|October 31, 2001
Changes in QUS and BMD measurements with antiresorptive therapy: a two-year longitudinal studyM L Frost, G M Blake, Fogelman
Scandinavian Journal of Rheumatology|March 18, 2000
The time of day that etidronate is ingested does not influence its therapeutic effect in osteoporosisG J Cook, G M Blake, I Fogelman
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 9, 2000
Contact quantitative ultrasound: an evaluation of precision, fracture discrimination, age-related bone loss and applicability of the WHO criteriaM L Frost, G M Blake, I Fogelman
Pageof 13